Search
for
Sort by
Research 931–960 of 1000+
- Evaluation of platelet‐rich plasma vs intralesional steroid in treatment of alopecia areata
- Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata: A Retrospective Study
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Study of the efficacy of carboxytherapy in alopecia
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Dermoscopy of alopecia areata in restrospective analysis
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Classification Framework for Healthy Hairs and Alopecia Areata: A Machine Learning (ML) Approach
- Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients
- Janus kinase inhibitors for alopecia areata
- Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Clinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Anxiety and Depression in Patients with Alopecia Areata in Eskisehir, Turkey
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- The Hairdex Quality of Life Instrument—A Translation and Psychometric Validation in Patients with Alopecia Areata
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Treatment options for alopecia areata
- 2‐deoxy D‐glucose treatment does not elicit a hair growth response in alopecia areata
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study